These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 5079133)
21. The immunotherapy of cancer. Parker CW Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047 [No Abstract] [Full Text] [Related]
22. [Interleukin-2 and cancer immunotherapy]. Ogarkov VI; Dobkin AI; Ryzhova EV; Okulov VB; Kiselev OI Vopr Onkol; 1989; 35(2):141-50. PubMed ID: 2648678 [No Abstract] [Full Text] [Related]
23. [Current status of immunotherapy in neoplasms]. Diaz-Rubio García E Rev Clin Esp; 1975 Dec; 139(6):487-96. PubMed ID: 766120 [No Abstract] [Full Text] [Related]
24. An insight into cancer immunology and immunotherapy. Thompson RB Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670 [No Abstract] [Full Text] [Related]
26. T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency. Rachelefsky GS; Stiehm ER; Ammann AJ; Cederbaum SD; Opelz G; Terasaki PI Pediatrics; 1975 Jan; 55(1):114-8. PubMed ID: 122863 [TBL] [Abstract][Full Text] [Related]
27. Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy. Pilch YH; Myers GH; Sparks FC; Golub SH Curr Probl Surg; 1975 Feb; ():1-61. PubMed ID: 1092529 [No Abstract] [Full Text] [Related]
29. Current concepts in the immunology of leprosy. Rea TH; Levan NE Arch Dermatol; 1977 Mar; 113(3):345-52. PubMed ID: 320942 [No Abstract] [Full Text] [Related]
30. [Cellular and humoral defense. Significance in hematology and immunopathology]. Tilz GP Med Klin; 1972 Mar; 67(10):341-5. PubMed ID: 5063220 [No Abstract] [Full Text] [Related]
31. Response in two groups of anergic patients to the transfer of leukocytes from sensitive donors. Rodriguez Paradisi E; De Bonaparte YP; Morgenfeld MC N Engl J Med; 1969 Apr; 280(16):859-61. PubMed ID: 4887076 [No Abstract] [Full Text] [Related]
32. Clinical aspects of cancer immunity. Moore GE Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116 [No Abstract] [Full Text] [Related]
33. Effect of transfer factor on lymphocyte function in anergic patients. Kirkpatrick CH; Rich RR; Smith TK J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419 [TBL] [Abstract][Full Text] [Related]
35. [The current position of the transfer factor investigation (author's transl)]. Schröder I Allerg Immunol (Leipz); 1978; 24(4):243-53. PubMed ID: 154287 [TBL] [Abstract][Full Text] [Related]
36. [Immunologic deficiencies and current trials in immunotherapy]. Schwick HG Verh Dtsch Ges Inn Med; 1987; 93():110-7. PubMed ID: 3442097 [No Abstract] [Full Text] [Related]
37. Preliminary results on the safety and efficacy of transfer factor in leprosy. Hastings RC; Morales MJ; Shannon EJ; Jacobson RR Int J Lepr Other Mycobact Dis; 1976; 44(1-2):275. PubMed ID: 945240 [No Abstract] [Full Text] [Related]